Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $112
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $85 to $112.
Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $85 to $112.